InflaRx IFRX
NASDAQ IFRX
$1.23 -0.08 (-6.49%)
As of: Nov 10, 2026 · 2:59 PM EST

InflaRx (IFRX) Receivables - Net (2024 - 2025)

Updated

Analysis

InflaRx (IFRX) Receivables - Net (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 InflaRx 85.79 Mn -160.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 2.11 Mn
Dec 31, 2024 1.87 Mn
Sep 30, 2024 97,815.19
Jun 30, 2024 25,407.99
Mar 31, 2024 38,041.88
API Access

InflaRx Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=IFRX&period=max&api_key=YOUR_API_KEY